Biontech Se ADR (BNTX)
$92.55
0.31 (0.34%)
BNTX Stock Quote Delayed 30 Minutes
Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19
Simply put, blockchain is the safest way to store and transfer information ever created, which makes it ideal for tracking vaccines.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
214,034
Day's Range
$91.60 - $93.54
52-Week Range
$85.21 - $125.83
Dividend & Yield
N/A (N/A)
BNTX Stock Predictions, Articles, and Biontech Se ADR News
BioNTech News: 5 Things for BNTX Stock Investors to Know
Shares of BNTX stock are flying on Monday after BioNTech and Pfizer announced extremely positive results from their Covid-19 vaccine trials.
Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results
Pfizer stock is rallying higher Monday on coronavirus vaccine results, and it's taking the rest of the stock market with it.
Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials
While I’d like to tell you Inovio Pharmaceuticals is a blood-in-the-streets opportunity, I can’t. Avoid INO stock for now.
BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding
BNTX stock is a high-risk high-return investment. BioNTech shares will likely to range-trade in the short run.
Pfizer Stock Pops on Vaccine Timeline News, Trial Expansion
Pfizer stock and partner BioNTech are rallying Monday morning on news the two companies could vaccinate Americans before the end of 2020.
Why Novavax Stock is Still a Strong Buy Even After an 800% Move
While NVAX stock could race higher on news in coming days of its clinical trials results, play this one safe with a trailing stop loss to safeguard any wins you have to date.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
Neon Therapeutics News: NTGN Stock Rockets 38% on BioNTech Deal
Neon Therapeutics (NTGN ) news for Thursday about a $67.00 million deal with BioNTech (BNTX) has NTGN stock soaring on Thursday.
